Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year  | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Novartis | Novartis | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
| Hoffmann-La Roche, Inc. | Roche | pharmaceuticals | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
| Actavis | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
| Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
| Boehringer Ingelheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
| Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
| Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
| Forest Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $790,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
| Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $625,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
| Pfizer Inc. and Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
| Sanofi-Aventis U.S. LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $828,500 |
| Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
| Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
| MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
| Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $25,616 |
| Pfizer Inc. | Pfizer | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $6,720 |
| Abraxis Bioscience, Inc. | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2012 | CA-SCAQMD | $5,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
| Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
| Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
| PFIZER, INC. | Pfizer | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $9,600 |
| SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $10,115 |
| ALEXION PHARMACEUTICALS, INC. | AstraZeneca | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $8,213 |
| MERCK SHARP & DOHME CORPORATION | Merck | pharmaceuticals | environmental violation | 2012 | EPA | $69,274 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
| Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
| King Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | $2,200,000 |
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | employment discrimination | 2013 | OFCCP | $51,594 |
| Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | USAO | $3,500,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Actavis Kadian, LLC | AbbVie | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $116,703 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $5,641 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $16,215 |
| SIGMA-ALDRICH INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $8,000 |
| SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $11,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
| Abbott Laboratories, Inc. | Abbott Laboratories | pharmaceuticals | consumer protection violation | 2013 | NY-AG | $25,000 |
| Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
| Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
| Apotex | Apotex Corp. | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| Astellas | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
| Aventis | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Biovail | Bausch Health | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $200,000 |
| Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
| Gilead Sciences | Gilead Sciences | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $250,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
| Lupin Pharmaceuticals | Lupin Limited | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $750,000 |
| Mylan Specialty L.P. | Viatris | pharmaceuticals | consumer protection violation | 2013 | OR-AG | $250,000 |
| Novartis | Novartis | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $750,000 |
| Par Pharmaceutical | Endo International | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
| Pernix Therapeutics | Currax Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
| Perrigo | Perrigo | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
| Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
| Shire | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
| Taro Pharmaceutical Industries | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
| UCB | UCB | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
| ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2013 | IN-ENV | $20,000 |
| E R SQUIBB & SONS LLC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2013 | NJ-ENV | $5,950 |
| Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | pharmaceuticals | air pollution violation | 2013 | CA-SCAQMD | $93,700 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
| AMGEN SF, LLC | Amgen | pharmaceuticals | workplace safety or health violation | 2013 | OSHA | $5,400 |
| AAIPHARMA SERVICES CORP. | Alcami | pharmaceuticals | workplace safety or health violation | 2013 | OSHA | $11,550 |
| NOVARTIS CONSUMER HEALTH INC. | Novartis | pharmaceuticals | workplace safety or health violation | 2013 | OSHA | $6,078 |
| ANIKA THERAPEUTICS INC. | Anika Therapeutics | pharmaceuticals | workplace safety or health violation | 2013 | OSHA | $5,800 |
| EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
| Celgene Corporation | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2013 | EPA | $6,035 |
| KING PHARMACEUTICALS | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
